Optimi Health (FRA:8BN0) Beneish M-Score: 15.29 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8BN0 Optimi Health Corp FRA:8BN0
48 GF Score
Price €3.87
GF Value €3.55
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Optimi Health Beneish M-Score?

Optimi Health FRA:8BN0 +0.65% 48 Beneish M-Score is 15.29 as of Jul. 14, 2026. GuruFocus rates FRA:8BN0 with a GF Score™ of 48/100 and a GF Value™ of €3.55 (Fairly Valued). The stock has 4 warning signs investors should review. Among 911 Drug Manufacturers companies, Optimi Health ranks worse than 99.01% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 15.29 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Optimi Health's Beneish M-Score or its related term are showing as below:

FRA:8BN0' s Beneish M-Score Range Over the Past 10 Years
Min: -3.11   Med: -0.44   Max: 17.52
Current: 15.29

During the past 6 years, the highest Beneish M-Score of Optimi Health was 17.52. The lowest was -3.11. And the median was -0.44.


Optimi Health Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Optimi Health's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Optimi Health Beneish M-Score Chart

Optimi Health Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Beneish M-Score
Get a 7-Day Free Trial 0.00 0.00 -3.11 -2.46 11.84

Optimi Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.96 1.30 11.84 15.60 15.29

FRA:8BN0 vs ZTS, UTHR: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Optimi Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optimi Health Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Optimi Health's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Optimi Health's Beneish M-Score falls into.


FRA:8BN0
48GF Score
Optimi Health Corp FRA:8BN0
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Optimi Health Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Optimi Health for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0555+0.528 * -0.7285+0.404 * 51.6214+0.892 * 0.4654+0.115 * 0.9277
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.8546+4.679 * -0.198638-0.327 * 1.994
=15.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was €0.03 Mil.
Revenue was 0.063 + 0 + -0.039 + 0.124 = €0.15 Mil.
Gross Profit was 0.056 + 0 + -0.286 + 0.115 = €-0.12 Mil.
Total Current Assets was €0.35 Mil.
Total Assets was €8.52 Mil.
Property, Plant and Equipment(Net PPE) was €7.62 Mil.
Depreciation, Depletion and Amortization(DDA) was €0.62 Mil.
Selling, General, & Admin. Expense(SGA) was €1.71 Mil.
Total Current Liabilities was €6.20 Mil.
Long-Term Debt & Capital Lease Obligation was €0.09 Mil.
Net Income was -1.004 + -0.962 + -0.831 + -0.575 = €-3.37 Mil.
Non Operating Income was 0 + 0 + 0.317 + 0 = €0.32 Mil.
Cash Flow from Operations was -0.21 + -0.394 + -0.849 + -0.544 = €-2.00 Mil.
Total Receivables was €0.06 Mil.
Revenue was 0.039 + 0.156 + 0.039 + 0.084 = €0.32 Mil.
Gross Profit was 0.028 + 0.114 + -0.004 + 0.042 = €0.18 Mil.
Total Current Assets was €0.54 Mil.
Total Assets was €8.84 Mil.
Property, Plant and Equipment(Net PPE) was €8.29 Mil.
Depreciation, Depletion and Amortization(DDA) was €0.62 Mil.
Selling, General, & Admin. Expense(SGA) was €1.98 Mil.
Total Current Liabilities was €2.10 Mil.
Long-Term Debt & Capital Lease Obligation was €1.17 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.028 / 0.148) / (0.057 / 0.318)
=0.189189 / 0.179245
=1.0555

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0.18 / 0.318) / (-0.115 / 0.148)
=0.566038 / -0.777027
=-0.7285

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (0.352 + 7.619) / 8.518) / (1 - (0.542 + 8.288) / 8.841)
=0.064217 / 0.001244
=51.6214

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=0.148 / 0.318
=0.4654

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.62 / (0.62 + 8.288)) / (0.618 / (0.618 + 7.619))
=0.0696 / 0.075027
=0.9277

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1.709 / 0.148) / (1.98 / 0.318)
=11.547297 / 6.226415
=1.8546

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.09 + 6.196) / 8.518) / ((1.174 + 2.098) / 8.841)
=0.737967 / 0.370094
=1.994

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-3.372 - 0.317 - -1.997) / 8.518
=-0.198638

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Optimi Health has a M-score of 15.22 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 15.29 mean?
Optimi Health (FRA:8BN0) has a Beneish M-Score of 15.29 as of Jul. 14, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Optimi Health and its competitors. According to the industry distribution chart, Optimi Health ranks #902 out of 911 companies in the Drug Manufacturers industry, placing it in the top 99%.
Is Optimi Health's Beneish M-Score too high?
Optimi Health's current Beneish M-Score is 15.29. Based on the distribution chart, Optimi Health ranks #902 out of 911 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Optimi Health has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Optimi Health's Beneish M-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Optimi Health ranks #902 out of 911 companies for Beneish M-Score. This places Optimi Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Optimi Health and its competitors. Optimi Health's current Beneish M-Score is 15.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimi Health stock overvalued right now?
Based on GuruFocus' analysis, Optimi Health (FRA:8BN0) is currently considered Fairly Valued. The stock's GF Value™ is €3.55, compared to a current price of €3.87 — trading 9% above its estimated fair value. The current Beneish M-Score is 15.29. Optimi Health's overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Optimi Health (FRA:8BN0), the current Beneish M-Score is 15.29 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Optimi Health (FRA:8BN0) Overvalued in 2026?

Based on GuruFocus' analysis, Optimi Health stock appears to be overvalued. The current stock price of €3.87 is trading 9% above its estimated GF Value™ of €3.55. GuruFocus considers Optimi Health to be Fairly Valued.

Key valuation signals for FRA:8BN0:

  • Beneish M-Score: 15.29
  • GF Value™: €3.55 vs. price of €3.87 (9% above fair value)
  • GF Score™: 48/100 with 4 warning signs

No single metric tells the full story. See the FRA:8BN0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Optimi Health Business Description

Address 269 David Brown Way, Po Box 728, Princeton, BC, CAN, V0X 1W0
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
48GF Score

Get the complete analysis for FRA:8BN0

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.87
Price
€3.55
GF Value